Syngene International Limited (SYNGENE) Share Price & AI Investment Analysis

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, i. Track Syngene International Limited's live NSE:SYNGENE share price ₹385.15 (+4.36%), market cap ₹₹155B, P/E 70.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SYNGENE — real-time NSE India stock intelligence.